Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization

Vaccine

Volumn 30, Issue 38, 2012, Pages 5644-5650

  Domínguez, Angela ^a,b   Castilla, Jesús ^b,c   Godoy, Pere ^b,d   Delgado Rodríguez, Miguel ^b,e   Martín, Vicente ^b,f   Saez, Marc ^b,g   Soldevila, Núria ^b   Quintana, José María ^b,h   Mayoral, José María ⁱ   Astray, Jenaro ^j   González Candelas, Fernando ^b,k   Cantón, Rafael ^b,l   Tamames, Sonia ^m   Castro, Ady ⁿ   Baricot, Maretva ^b   Alonso, Jordi ^b,o   Pumarola, Tomás ^p  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^d GENERALITAT DE CATALUNYA   (Spain)

^e UNIVERSITY OF JAÉN   (Spain)

^f UNIVERSITY OF LEÓN   (Spain)

^g UNIVERSITY OF GIRONA   (Spain)

^h Hospital Galdakao Usansolo   (Spain)

ⁱ Servicio de Vigilancia de Andalucia   (Spain)

^j Comunidad de Madrid ^*  (Spain)

^k UNIVERSITY OF VALENCIA   (Spain)

^l HOSPITAL RAMÓN Y CAJAL   (Spain)

^m Direccion General de Salud Publica e Investigacion Desarrollo e Innovacion   (Spain)

ⁿ INSTITUTO DE SALUD CARLOS III   (Spain)

^o INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^p Red Espanola de Investigacion en Patologia Infecciosa REIPI   (Spain)

more..

Author keywords

Effectiveness; Pandemic vaccine; Seasonal influenza vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEASONAL INFLUENZA; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 84864764258     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.090     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR 2009, 58:400-402.
2. Garcia-García L., Valdespino-Gómez J.L., Lazcano-Ponce E., Jimenez-Corona A., Higuera-Iglesias A., Cruz-Hervert P., et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009, 339:b3928.
3. Echevarría-Zuno S., Mejía-Aranguré J.M., Mar-Obeso A.J., Grajales-Muñiz C., Robles-Pérez E., González-León M., et al. Infection and death from influenza AH1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079.
4. Johns M.C., Eick A.A., Blazes D.L., Lee S.E., Perdue C.L., Lipnick R., et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 2010, 5:e10722.
5. Pelat C., Falchi A., Carrat F., Mosnier A., Bonmarin I., Turbelin C., et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011, 6:e19621.
6. Kelly H.A., Grant K.A., Fielding J.E., Carville K.S., Looker C.O., Tran T., et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011, 29:6419-6426.
7. Valenciano M., Kissling E., Cohen J.M., Oroszi B., Barret A.S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8:e1000388.
8. Castilla J., Morán J., Martínez-Artola V., Fernández-Alonso M., Guevara M., Cenoz M.G., et al. Effectiveness of the monovalent influenza A(H1N1) 2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. Vaccine 2011, 29:5919-5924.
9. Italian Multicenter Study Group for Drug and Vaccine Safety in Children Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study. BMJ Open 2011, 1:e000167.
10. Larrauri A., Savulescu C., Jiménez-Jorge S., Pérez-Breña P., Pozo F., Casas I., et al. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Gac Sanit 2011, 25:23-28.
11. Pellegrini M., Nicolay U., Lindert K., Groth N., Della Cioappa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 2009, 27:6959-6965.
12. Roman F., Vaman T., Gerlach B., Markendof A., Gillard P., Devaster J.M. Immunogenicity and safety in adults of one dose of influenza AH1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observed-blind, randomized trial. Vaccine 2010, 28:1740-1745.
13. World Health Organization WHO (2009a) CDC Protocol of Realtime RTPCR for Influenza A (H1N1) October 2009, Available from: http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf.
14. European Commission. Commission decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No. 2119/98/EC of the European Parliament and of the Council. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=OJ%3AL%3A2009%3A110%3A0058%3A0059%3AEN%3APDF.
15. Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., SebastianPillai P., et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1) 2009 infection in England and Scotland 2009-2010. Euro Surveill 2011, 16. pii:19763.
16. Puig-Barberà J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Pérez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28:7460-7467.
17. Simpson C.R., Ritchie L.D., Robertson C., Sheikh A., McMenanim J. Vaccine effectiveness in pandemic influenza-primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 2010, 14:313-316.
18. Sterne J.A., White I.R., Carlin J.B., Spratt M., Royston P., Kenward M.G., et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 338:b2393.
19. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
20. Song J.Y., Cheong H.J., Heo J.Y., Noh J.Y., Choi W.S., Park D.W., et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011, 29:1395-1398.
21. Wichmann O., Stocker P., Poggensee G., Altmann D., Walter D., Hellenbrand W., et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 2010, 15:pii:19561.
22. Wu J., Xu F., Lu L., Lu M., Miao L., Gao T., et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010, 363:2416-2423.
23. Andrews N., Waight P., Yung C.F., Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011, 203:32-39.
24. Ortqvist A., Berggren I., Insulander M., de Jong B., Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011, 52:1203-1211.
25. Hardelid P., Fleming D.M., Andrews N., Barley M., Durnall H., Mangtani P., et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine 2012, 30:1371-1378.
26. Kavanagh K., Roberston C., McMenamin J. Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach. PLoS One 2011, 6:e28743.
27. Steens A., Wijnans E.G., Dieleman J.P., Sturkenboom M.C., van der Sande M.A., van der Hoek W. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalization: a matched case-control study. BMC Infect Dis 2011, 11:196.
28. Savulescu C., Jiménez-Jorge S., de Mateo S., Pozo F., Casas I., Perez Breña P., et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health 2011, 11:899.
29. Paño-Pardo J.R., Martín-Quirós A., Romero-Gómez M., Maldonado J., Martín-Vega A., Rico-Nieto A., et al. Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half. Clin Microbiol Infect 2011, 17:845-850.